Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 28122247
Kremer JC, et al. (2017) Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers. Cell Rep 18, 991-1004 28122247
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

Y10-p - LDH-A (human)
Modsite: tLkDQLIyNLLkEEQ SwissProt Entrez-Gene
Orthologous residues
LDH‑A (human): Y10‑p, LDH‑A iso2 (human): Y10‑p, LDH‑A iso3 (human): Y39‑p, LDH‑A (mouse): V10‑p, LDH‑A (rat): V10‑p, LDH‑A (chicken): H9‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Disease tissue studied:  melanoma skin cancer, leiomyosarcoma
Relevant cell lines - cell types - tissues:  SK-LMS-1 (muscle cell), SK-MEL2 (melanocyte), SKUT-1
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
ADI-PEG20 decrease
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced

S300-p - PDHA1 (human)
Modsite: sMsDPGVsyRtREEI SwissProt Entrez-Gene
Orthologous residues
PDHA1 (human): S300‑p, PDHA1 iso2 (human): S307‑p, PDHA1 iso4 (human): S338‑p, PDHA1 (mouse): S300‑p, PDHA1 (rat): S300‑p, PDHA1 (pig): S299‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Disease tissue studied:  melanoma skin cancer, leiomyosarcoma
Relevant cell lines - cell types - tissues:  SK-LMS-1 (muscle cell), SK-MEL2 (melanocyte), SKUT-1
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
ADI-PEG20 increase
Downstream Regulation
Effect of modification (function):  enzymatic activity, inhibited